The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, randomised, phase III trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients. The STAD-1 trial.
 
Alessandro Morabito
No Relationships to Disclose
 
Gennaro Daniele
Honoraria - Bayer Schering Pharma
 
Adolfo G. Favaretto
No Relationships to Disclose
 
Virginio Filipazzi
No Relationships to Disclose
 
Antonio Rossi
No Relationships to Disclose
 
Vittorio Gebbia
No Relationships to Disclose
 
Federico Castiglione
Travel, Accommodations, Expenses - Celgene; Johnson & Johnson
 
Luigi Cavanna
No Relationships to Disclose
 
Evaristo Maiello
No Relationships to Disclose
 
Giuseppe Valmadre
No Relationships to Disclose
 
Raffaele Costanzo
No Relationships to Disclose
 
Anna Manzo
No Relationships to Disclose
 
Laura Bonanno
No Relationships to Disclose
 
Elena Piazza
No Relationships to Disclose
 
Paolo Maione
No Relationships to Disclose
 
Gianfranco Mancuso
No Relationships to Disclose
 
Massimo Di Maio
Honoraria - Bayer Schering Pharma; Boehringer Ingelheim; Lilly; Merck Sharp & Dohme; Pfizer
Consulting or Advisory Role - Bayer Schering Pharma; Boehringer Ingelheim; Lilly; Novartis
Speakers' Bureau - Boehringer Ingelheim
 
Maria Carmela Piccirillo
No Relationships to Disclose
 
Ciro Gallo
No Relationships to Disclose
 
Cesare Gridelli
No Relationships to Disclose